UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event
reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
|
|
||
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number,
including area code: (
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| The |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
Item 2.02 Results of Operations and Financial Condition.
On May 16, 2023, Ispire Technology Inc. (the “Company,” “we,” “us,” “our”) issued a press release announcing results for the three and nine months ended March 31, 2023. A copy of the press release is submitted hereto as Exhibit 99.1 and is incorporated herein by reference.
The information contained in this Current Report on Form 8-K, including the exhibit hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words “expect,” “believe,” “estimate,” “intend,” “plan,” “anticipate,” “may,” “should,” “strategy,” “future,” “will,” “project,” “potential” and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include, but are not limited to the Company’s ability to generate the forecast revenue; the Company’s ability to develop and market new products; the effects of regulations relating to the marketing and sale of vaping products in the United States and other countries; the expected growth of, and trends in, the markets for our products and services in the markets in which jurisdictions that we sell our products; the Company’s ability to establish and operate manufacturing facilities in Vietnam and Los Angeles; and the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Special Note Regarding Forward-Looking Statements” and the additional risks described in the Company’s prospectus dated April 3, 2023 and in “Management’s Discussion of Financial Condition and Results of Operations” in the Company’s Form 10-Q quarterly report for the quarter ended March 31, 2023.
You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the prospectus relate only to events or information as of the date on which the statements are made in the prospectus. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.
Item 9.01. Financial Statements and Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press release, dated May 16, 2023 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| May 16, 2023 | Ispire Technology Inc. | ||
| By: | /s/ Tuanfang Liu | ||
| Name: | Tuanfang Liu | ||
| Title: | Chief Executive Officer | ||
2
Exhibit 99.1
Ispire Technology Inc. Reports Financial Results for the Third Quarter 2023
Revenue Increased 26.9% to $24.1 Million; Gross Profit Increased 51.9% to $4.5 Million; Net Loss of $3.3 Million for the Quarter, up from a $1.0 Million Net Loss in the Third Quarter 2022
Issues Fourth Quarter 2023 Outlook for Cannabis Vaping Products, Representing Growth of 58% to 98%
Los Angeles, Calif. – May 16, 2023 – Ispire Technology Inc. (NASDAQ: ISPR) (“Ispire” or the “Company”), a leader in vapor technology, providing high-quality, innovative products with first-class performance, today reported financial results for the third quarter of 2023, which ended on March 31, 2023, and filed its quarterly report on Form 10-Q on May 15, 2023. The Company’s fiscal year is the year ending on June 30, 2023.
“We are very pleased with our financial results during our third quarter. Revenue growth was a robust 26.9% while gross profit grew 51.9% due to a favorable product mix and the realization of economies of scale on higher sales volume. We look forward to a strong finish to the fiscal year with a projected sequential revenue increase for cannabis vaping products of between 58% and 98% during our fourth quarter,” said Michael Wang, CFO of Ispire.
He added, “As we begin our journey as a public company, we are focused on a multi-prong strategy directed at increasing sales of our e-cigarette vaporizer technology products and developing our cannabis vaporizer technology products with a focus on both medical and recreational usages. We firmly believe that Ispire offers the very best products in the marketplace and has rightfully earned an enviable reputation among its customers. We continue to seek to remain at the forefront of technology so that we can adapt to emerging trends and thereby enhance value for all of our shareholders.”
Third Quarter 2023 Highlights
| ● | Revenue increased 26.9% to $24.1 million as compared to $19.0 million in the same period of 2022. Tobacco vaping products contributed $16.5 million and cannabis vaping products contributed $7.6 million to revenue during the third quarter 2023; |
| ● | Gross profit increased 51.9% to $4.5 million as compared to $3.0 million in the same period of 2022; |
| ● | Gross margin increased to 18.7% as compared to 15.7% in the same period of 2022. |
| ● | Total operating expenses increased 106.2% to $8.0 million as compared to $3.9 million in the same period of 2022; and |
| ● | Net loss of $3.1 million as compared to net loss of $1.0 million in the same period of 2022. |
Liquidity and Capital Resources
As of March 31, 2023, and prior to the closing of its initial public offering, Ispire had cash and cash equivalents of $24.0 million and working capital of $5.2 million.
The Company believes that its current cash and cash flows provided by operating activities, and the net proceeds from the initial public offering will be sufficient to meet its working capital needs in the next 12 months.
Initial Public Offering
In April 2023, Ispire closed on its initial public offering of 3,105,000 shares of common stock, which included the 405,000 shares issued pursuant to the full exercise by the underwriters of their overallotment option, at the initial public offering price of $7.00 per share. The common stock began trading on the NASDAQ Capital Market on April 4, 2023.
Including proceeds from the sale of the additional shares, the aggregate gross proceeds from the offering were approximately $21.7 million, less underwriting discounts and non-accountable expense allowance of approximately $1.7 million, and other expenses of approximately $1.5 million, resulting in net proceeds of $18.5 million.
Net proceeds from the initial public offering are being used for:
| ● | Approximately 35% to develop manufacturing operations in Vietnam and the United States; |
| ● | Approximately 25% for research and development activities, which include efforts to develop new products and new vaping technology; |
| ● | Approximately 20% for the marketing and promotion of the Company’s branded products; and |
| ● | The balance of approximately 20% for general administration and working capital. |
Outlook
Ispire is providing the following outlook for the cannabis vaping products for the fourth quarter 2023, which ends on June 30, 2023. Ispire commenced marketing cannabis vaping products in mid 2020, and revenue from cannabis vaping products was $7.6 million for the third quarter of 2023. Revenue for cannabis vaping products for the fourth quarter is projected at $12 million to $15 million, representing growth of 58% to 98% from the third quarter 2023.
About Ispire Technology Inc.
Ispire is engaged in the R&D, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company has or licenses from a related party more than 200 invention/design patents received or filed globally. Ispire’s tobacco vaping products are marketed under the Aspire brand name and are sold worldwide (except in the People’s Republic of China and Russia) primarily through its distribution network. Ispire’s cannabis vaping products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire currently sells its cannabis vaping hardware only in the United States, and it recently commenced marketing activities in Canada and Europe, primarily in the European Union.
Please visit www.ispiretechnology.com and follow us on Facebook, Twitter, Instagram, Linkedin, Pinterest, and YouTube. Any information contained on, or that can be accessed through, the Company’s website, any other website or any social media, is not a part of this press release.
2
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. The words “expect,” “believe,” “estimate,” “intend,” “plan,” “anticipate,” “may,” “should,” “strategy,” “future,” “will,” “project,” “potential” and similar expressions indicate forward-looking statements. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. These risks and uncertainties include, but are not limited to Ispire’s ability to generate the forecast revenue; Ispire’s ability to develop and market new products; the effects of regulations relating to the marketing and sale of vaping products in the United States and other countries; the expected growth of, and trends in, the markets for our products and services in the markets in which jurisdictions that we sell our products;; Ispire’s ability to establish and operate manufacturing facilities in Vietnam and Los Angeles;; and the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Special Note Regarding Forward-Looking Statements” and the additional risk described in Ispire’s prospectus dated April 3, 2023 and in Management’s Discussion of Financial Condition and Results of Operations in Ispire’s Form 10-Q quarterly report for the quarter ended March 31, 2023.
You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the prospectus relate only to events or information as of the date on which the statements are made in the prospectus. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.
Investor Relations Contact:
Raphael Gross
203.682.8253
ir@ispiretechnology.com
3
ISPIRE TECHNOLOGY INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
| June 30, | March 31, | |||||||
| 2022 | 2023 | |||||||
| Assets | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 74,480,651 | $ | 24,035,608 | ||||
| Accounts receivable, net | 8,260,574 | 15,412,769 | ||||||
| Held-to-maturity investment | - | 9,604,418 | ||||||
| Inventories, net | 14,580,557 | 14,237,162 | ||||||
| Prepaid expenses and other current assets | 192,499 | 290,616 | ||||||
| Due from related parties | 1,934,855 | - | ||||||
| Total current assets | 99,449,136 | 63,580,573 | ||||||
| Other assets: | ||||||||
| Property, plant and equipment, net | 114,025 | 588,213 | ||||||
| Rental deposit | 876,100 | 721,497 | ||||||
| Right-of-use assets | 295,804 | 4,359,274 | ||||||
| Intangible assets | - | 72,714,652 | ||||||
| Total other assets | 1,285,929 | 78,383,636 | ||||||
| Total assets | $ | 100,735,065 | $ | 141,964,209 | ||||
| Liabilities and stockholders’ equity | ||||||||
| Current liabilities | ||||||||
| Accounts payable | $ | 290,541 | $ | 178,140 | ||||
| Accounts payable – related party | 41,982,373 | 56,044,267 | ||||||
| Contract liabilities | 1,672,051 | 742,247 | ||||||
| Dividends payable | 3,362,639 | - | ||||||
| Accrued liabilities and other payables | 159,296 | 520,057 | ||||||
| Due to related parties | 40,672,768 | - | ||||||
| Income tax payable | 481,113 | - | ||||||
| Lease liabilities | 347,541 | 917,310 | ||||||
| Total current liabilities | 88,968,322 | 58,402,021 | ||||||
| Other liabilities: | ||||||||
| Lease liabilities | - | 3,608,580 | ||||||
| Total liabilities | $ | 88,968,322 | $ | 62,010,601 | ||||
| Stockholders’ equity: | ||||||||
| Common stock, par value $0.0001 per share; 140,000,000 shares authorized; 50,000,000 shares issued and outstanding as of June 30 2022 and March 31, 2023 | 5,000 | 5,000 | ||||||
| Preferred stock, par value $0.0001 per share, 10,000,000 shares authorized, no shares issued at June 30, 2022 and March 31, 2023 | - | - | ||||||
| Capital contribution | - | 74,259,915 | ||||||
| Accumulated other comprehensive loss | (184,664 | ) | (199,938 | ) | ||||
| Retained earnings | 11,946,407 | 5,888,631 | ||||||
| Total stockholders’ equity | 11,766,743 | 79,953,608 | ||||||
| Total liabilities and stockholders’ equity | $ | 100,735,065 | $ | 141,964,209 | ||||
4
ISPIRE TECHNOLOGY INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS
OF OPERATIONS AND
COMPREHENSIVE INCOME
| Three Months Ended March 31, | Nine Months Ended March 31, | |||||||||||||||
| 2022 | 2023 | 2022 | 2023 | |||||||||||||
| Revenue | $ | 19,014,149 | $ | 24,136,297 | $ | 66,247,507 | $ | 82,976,746 | ||||||||
| Cost of revenue | 16,038,425 | 19,616,098 | 55,959,959 | 68,525,866 | ||||||||||||
| Gross profit | 2,975,724 | 4,520,199 | 10,287,548 | 14,450,880 | ||||||||||||
| Operating expenses: | ||||||||||||||||
| Sales and marketing expenses | 1,325,024 | 948,302 | 3,781,183 | 3,355,830 | ||||||||||||
| General and administrative expenses | 2,546,379 | 7,033,958 | 5,618,260 | 16,234,767 | ||||||||||||
| Total Operating Expenses | 3,871,403 | 7,982,260 | 9,399,443 | 19,590,597 | ||||||||||||
| (Loss)income from operations | (895,679 | ) | (3,462,061 | ) | 888,105 | (5,139,717 | ) | |||||||||
| Other income(expense): | ||||||||||||||||
| Interest income, net | 1,016 | 391 | 2,083 | 77,202 | ||||||||||||
| Exchange gain, net | 68,420 | 660,760 | 136,902 | 183,178 | ||||||||||||
| Other (expense)income, net | (5,559 | ) | (67,953 | ) | 49,382 | (108,440 | ) | |||||||||
| Total Other income, net | 63,877 | 593,198 | 188,367 | 151,940 | ||||||||||||
| (Loss) income before income taxes | (831,802 | ) | (2,868,863 | ) | 1,076,472 | (4,987,777 | ) | |||||||||
| Income taxes - current | (158,755 | ) | (237,992 | ) | (788,348 | ) | (1,069,999 | ) | ||||||||
| Net (loss)income | $ | (990,557 | ) | $ | (3,106,855 | ) | $ | 288,124 | $ | (6,057,776 | ) | |||||
| Other comprehensive loss | ||||||||||||||||
| Foreign currency translation adjustments | (71,687 | ) | (157,704 | ) | (80,765 | ) | (15,274 | ) | ||||||||
| Comprehensive (loss)income | $ | (1,062,244 | ) | $ | (3,264,559 | ) | $ | 207,359 | $ | (6,073,050 | ) | |||||
| Net (loss)income per share | ||||||||||||||||
| Basic and diluted | $ | (0.02 | ) | $ | (0.06 | ) | $ | 0.01 | $ | (0.12 | ) | |||||
| Weighted average shares outstanding: | ||||||||||||||||
| Basic and diluted | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 | ||||||||||||
5
ISPIRE TECHNOLOGY INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months ended March 31, | ||||||||
| 2022 | 2023 | |||||||
| Net income (loss): | $ | 288,124 | $ | (6,057,776 | ) | |||
| Adjustments to reconcile net income from operations to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 3,907 | 1,566,141 | ||||||
| Depreciation of right-of-use assets | 215,690 | 763,641 | ||||||
| Accounts receivable impairment | - | 2,226,090 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (5,398,432 | ) | (9,323,279 | ) | ||||
| Inventories | (6,869,171 | ) | 343,395 | |||||
| Prepaid expenses and other current assets | 77,987 | 56,486 | ||||||
| Accounts payable | (13,320,148 | ) | 13,737,398 | |||||
| Contract liabilities | 471,745 | (940,014 | ) | |||||
| Accrued liabilities and other payables | 323,866 | 360,761 | ) | |||||
| Income tax payable | 202,759 | (481,113 | ) | |||||
| Net cash (used in)provided by operating activities | $ | (24,003,673 | ) | $ | 2,251,730 | |||
| Cash flows from investing activities: | ||||||||
| Purchase of property, plant and equipment | (120,948 | ) | (495,065 | ) | ||||
| Purchase of short-term investment | - | (9,604,418 | ) | |||||
| Net cash used in investing activities | $ | (120,948 | ) | $ | (10,099,483 | ) | ||
| Cash flows from financing activities: | ||||||||
| Payment made for dividends | (449,026 | ) | (3,384,678 | ) | ||||
| Advances from related parties | 1,681,723 | 1,934,855 | ||||||
| Repayment of advances from related parties | (1,804,786 | ) | (40,512,691 | ) | ||||
| Principal portion of lease payment | (203,612 | ) | (634,776 | ) | ||||
| Net cash used in financing activities | $ | (775,701 | ) | $ | (42,597,290 | ) | ||
| Net decrease in cash and cash equivalents | (24,900,322 | ) | (50,445,043 | ) | ||||
| Cash and cash equivalents - beginning of period | 85,248,997 | 74,480,651 | ||||||
| Cash and cash equivalents - end of period | $ | 60,348,675 | $ | 24,035,608 | ||||
6